← Open Payments lookup

ALANNA KAVANAUGH: Open Payments

NPI 1912448937 · NEW YORK, NY. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.

See the full provider profile for registry, prescribing and billing details.

Industry payments (Sunshine Act)

Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.

$4,460 in 28 payments from 14 companies in 2025. Trend: 2023 $1,437 · 2024 $8,073 · 2025 $4,460

Food & beverage: $3,035Consulting: $1,200Travel & lodging: $225
CompanyPaymentsAmount
Boehringer Ingelheim Pharmaceuticals, Inc.3$1,355
AstraZeneca Pharmaceuticals LP7$921
GENZYME CORPORATION3$425
Otsuka America Pharmaceutical, Inc.3$400
United Therapeutics Corporation3$243
Otsuka Pharmaceutical Development & Commercialization, Inc.1$150
Madrigal Pharmaceuticals1$150
Novartis Pharmaceuticals Corporation1$140
E.R. Squibb & Sons, L.L.C.1$129
Takeda Pharmaceuticals U.S.A., Inc.1$125

Products named: BREZTRI, DUPIXENT, ABILIFY MAINTENA, IMFINZI, FASENRA, REZDIFFRA, COBENFY, JARDIANCE.

Industry payments across NY — which companies pay providers there.